Canadian researchers say that it may be possible to compensate for the key brain protein missing in Fragile X patients, opening the way to a possible therapy that can reverse symptoms of the disease. And that insight into the neurotransmitter dopamine is expected to inspire new clinical trials.
"Something that you thought was not curable, and not treatable, you (may be able to) actually change," said Dr. Carlo Paribello, founder of the Fragile X Research Foundation of Canada.
- check out the story from Toronto Star